As the complexity, size, length, and globalisation of clinical trials have steadily increased, so too have trial costs. A recent study estimated the average cost of bringing a drug to market at around $2.6 billion. Rik van Mol at Veeva Vault Europe discusses why sponsors are increasingly relying on contract research organisations (CROs).